These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17604958)

  • 1. The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study.
    Kim JB; Spevack DM; Tunick PA; Bullinga JR; Kronzon I; Chinitz LA; Reynolds HR
    J Am Soc Echocardiogr; 2008 Mar; 21(3):284-7. PubMed ID: 17604958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pacemaker and implantable cardioverter defibrillator electrodes on tricuspid regurgitation and right sided heart functions.
    Arabi P; Özer N; Ateş AH; Yorgun H; Oto A; Aytemir K
    Cardiol J; 2015; 22(6):637-44. PubMed ID: 26412607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tricuspid regurgitation and implantable devices.
    Al-Bawardy R; Krishnaswamy A; Rajeswaran J; Bhargava M; Wazni O; Wilkoff B; Tuzcu EM; Martin D; Thomas J; Blackstone E; Kapadia S
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):259-66. PubMed ID: 25377489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of right ventricular apical pacing with transvenous pacemaker and implantable cardioverter defibrillator on mitral and tricuspid regurgitation.
    Fanari Z; Hammami S; Hammami MB; Hammami S; Shuraih M
    J Electrocardiol; 2015; 48(5):791-7. PubMed ID: 26216371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tricuspid Regurgitation Following Implantation of Endocardial Leads: Incidence and Predictors.
    Lee RC; Friedman SE; Kono AT; Greenberg ML; Palac RT
    Pacing Clin Electrophysiol; 2015 Nov; 38(11):1267-74. PubMed ID: 26234305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricuspid insufficiency does not increase early after permanent implantation of pacemaker leads.
    Kucukarslan N; Kirilmaz A; Ulusoy E; Yokusoglu M; Gramatnikovski N; Ozal E; Tatar H
    J Card Surg; 2006; 21(4):391-4. PubMed ID: 16846419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term effects of permanent pacemaker implantation on tricuspid valve regurgitation].
    Ren CL; Wang Y; Wang R; Li BJ; Geng RY; Gao CQ
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(30):2118-22. PubMed ID: 23158275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worsening tricuspid regurgitation associated with permanent pacemaker and implantable cardioverter-defibrillator implantation: A systematic review and meta-analysis of more than 66,000 subjects.
    Alnaimat S; Doyle M; Krishnan K; Biederman RWW
    Heart Rhythm; 2023 Nov; 20(11):1491-1501. PubMed ID: 37506990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioprosthetic tricuspid valve regurgitation associated with pacemaker or defibrillator lead implantation.
    Eleid MF; Blauwet LA; Cha YM; Connolly HM; Brady PA; Dearani JA; Espinosa RE
    J Am Coll Cardiol; 2012 Feb; 59(9):813-8. PubMed ID: 22361401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transvenous pacemaker leads do not worsen tricuspid regurgitation: a prospective echocardiographic study.
    Leibowitz DW; Rosenheck S; Pollak A; Geist M; Gilon D
    Cardiology; 2000; 93(1-2):74-7. PubMed ID: 10894910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads.
    Lin G; Nishimura RA; Connolly HM; Dearani JA; Sundt TM; Hayes DL
    J Am Coll Cardiol; 2005 May; 45(10):1672-5. PubMed ID: 15893186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation.
    Nazmul MN; Cha YM; Lin G; Asirvatham SJ; Powell BD
    Europace; 2013 Mar; 15(3):409-13. PubMed ID: 23193162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of transvenous ventricular pacing leads on tricuspid regurgitation in pediatric and congenital heart disease patients.
    Webster G; Margossian R; Alexander ME; Cecchin F; Triedman JK; Walsh EP; Berul CI
    J Interv Card Electrophysiol; 2008 Jan; 21(1):65-8. PubMed ID: 18040765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tricuspid insufficiency after laser lead extraction.
    Rodriguez Y; Mesa J; Arguelles E; Carrillo RG
    Pacing Clin Electrophysiol; 2013 Aug; 36(8):939-44. PubMed ID: 23713555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of severe tricuspid regurgitation in patients with permanent pacemaker or automatic implantable cardioverter-defibrillator leads.
    Najib MQ; Vittala SS; Challa S; Raizada A; Tondato FJ; Lee HR; Chaliki HP
    Tex Heart Inst J; 2013; 40(5):529-33. PubMed ID: 24391312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of transvenous lead extraction on tricuspid valve function.
    Coffey JO; Sager SJ; Gangireddy S; Levine A; Viles-Gonzalez JF; Fischer A
    Pacing Clin Electrophysiol; 2014 Jan; 37(1):19-24. PubMed ID: 23991637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, Risk Factors, and Prognosis of Tricuspid Regurgitation After Cardiac Implantable Electronic Device Implantation: A Systematic Review and Meta-analysis.
    Zhang XX; Wei M; Xiang R; Lu YM; Zhang L; Li YD; Zhang JH; Xing Q; Tu-Erhong ZK; Tang BP; Zhou XH
    J Cardiothorac Vasc Anesth; 2022 Jun; 36(6):1741-1755. PubMed ID: 34389210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Implantable Cardioverter-Defibrillator Leads on the Tricuspid Valve and Right Ventricle: A Randomized Trial.
    Leong DP; Dokainish H; Mondésert B; Cavalli G; Khetan A; Cirne F; Baro Vila R; Klimis H; De Jesus TA; AlGhasab NS; Akbari V; Suliman A; Eltebi O; Almhri A; Ferdous T; Djuric A; Bashir J; Krahn AD; Exner DV; Philippon F; Birne DH; Joza J; Healey JS
    JACC Clin Electrophysiol; 2024 Sep; 10(9):2088-2096. PubMed ID: 39001765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transvenous Extraction of Pacemaker and Defibrillator Leads and the Risk of Tricuspid Valve Regurgitation.
    Park SJ; Gentry JL; Varma N; Wazni O; Tarakji KG; Mehta A; Mick S; Grimm R; Wilkoff BL
    JACC Clin Electrophysiol; 2018 Nov; 4(11):1421-1428. PubMed ID: 30466846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echocardiography-guided Cardiac Implantable Electronic Device Implantation to Reduce Device Related Tricuspid Regurgitation: A Prospective Controlled Study.
    Marincheva G; Levi T; Perelshtein Brezinov O; Valdman A; Rahkovich M; Kogan Y; Laish-Farkash A
    Isr Med Assoc J; 2022 Jan; 24(1):25-32. PubMed ID: 35077042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.